300558 Betta Pharmaceuticals
- 53.80
- +2.18+4.22%
About Betta Pharmaceuticals Company
Established in 2003, the company is a high-tech pharmaceutical enterprise founded by a team of high-level talents returning from overseas, integrating R&D, production and marketing with independent intellectual property research and development as the core. On November 7, 2016, Betta Pharmaceuticals was listed on the Shenzhen Stock Exchange. The company is a national high-tech enterprise founded by Dr. Overseas Returning, with research and development of innovative drugs with independent intellectual property as the core, integrating R&D, production and marketing. The company's main products Kaimena, Bemena, Beantin, SEMENA, and Vomena are chemical pharmaceuticals. Corporate honors: Chairman Ding Lieming won the title of “Outstanding Person in the Overseas Chinese Community”; Gao Yaqin, the company's senior QC commissioner, won the National May 1st Labor Medal; Chairman Ding Lieming won the Zhejiang Science and Technology Significant Contribution Award; Beida Pharmaceutical won the first “Four Strong Provinces” leading enterprise in Zhejiang; Dr. Ding Lieming won the first “Global Zhejiang Gold Award”, etc.
Company Profile
Company Executives
- Name
- Position
- Salary
- lieming ding
- Chairman, Directors, General Manager, CEOs, Nomination Committee Members, Strategy Committee Convener
- 2.90M
- tian xu
- Directors, Member of the Remuneration and Assessment Committee
- --
- shizhe ding
- Directors
- --
- jiang wan
- Directors, Senior Vice President, Strategy Committee Member, Chief Operating Officer
- 2.55M
- zhihua yu
- Directors, Audit Committee Member
- --
- jia tong
- Directors, CEO, Strategy Committee Member
- 1.46M
- jianxun fan
- Directors, VP, Chief Financial Officer, Strategy Committee Member
- 1.46M
- JIANGNAN CAI
- Independent Directors, Remuneration and Assessment Committee Convener, Nomination Committee Members
- 120.00K
- wei wang
- Independent Directors, Audit Committee Member, Member of the Remuneration and Assessment Committee
- 120.00K
- jiajia xiao
- Independent Directors, Audit Committee Member, Nomination Committee Convener
- 120.00K
- xinqi huang
- Independent Directors, Member of the Remuneration and Assessment Committee, Audit Committee Convener
- 120.00K
- lingxi wu
- Board Secretary, Head of the Internal Audit Department
- 995.60K
- jianhao shen
- Securities Affairs Representative
- --
- yangnan zhang
- Chairman of the Supervisory Board, Auditors
- 870.70K
- rong wang
- Auditors
- --
- fei wu
- Employee Supervisors
- 860.20K
Analysis
Price Target
No Data
No Data